Carolina Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
COPPSERS
Carolina Wealth Advisors's GILD Position: Q2 2026 in Review
Carolina Wealth Advisors reduced its Gilead Sciences (GILD) stake by 100% in Q2 2026, selling an estimated $4.69M and leaving 156 shares worth $19.7K. The position accounts for 0.01% of the portfolio, ranked #159.
Carolina Wealth Advisors first reported a position in GILD in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.99M in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Carolina Wealth Advisors held 156 shares of Gilead Sciences worth $19.7K as of Q2 2026.
- Carolina Wealth Advisors sold 35,625 Gilead Sciences shares in Q2 2026, an estimated $4.69M.
- Gilead Sciences made up 0.01% of Carolina Wealth Advisors's portfolio in Q2 2026, its #159 holding.
- Carolina Wealth Advisors first reported a position in Gilead Sciences in Q4 2019 and has held it in 25 quarters since.
- Carolina Wealth Advisors's Gilead Sciences position peaked at $4.99M in Q1 2026.
- 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Carolina Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.